Steroid Receptor Research Center

Publications by the research group members

• AR and ERG drive the expression of prostate cancer specific long noncoding RNAs Kohvakka, Annika; Sattari, Mina; Shcherban, Anastasia; Annala, Matti; Urbanucci, Alfonso; Kesseli, Juha; Tammela, Teuvo L J; Kivinummi, Kati; Latonen, Leena; Nykter, Matti; Visakorpi, Tapio. 2020. AR and ERG drive the expression of prostate cancer specific long noncoding RNAs Oncogene [Online ahead of print 2020 Jun 17]: 1-11. 2020
• BCOR-coupled H2A monoubiquitination represses a subset of androgen receptor target genes regulating prostate cancer proliferation Lempiäinen, JK; Manjur, ABMK; Malinen, M; Ketola, K; Niskanen, EA; Palvimo, JJ. 2020. BCOR-coupled H2A monoubiquitination represses a subset of androgen receptor target genes regulating prostate cancer proliferation Oncogene 39: 2391-2407. 2020
• Histonien muokkaukset ja geenien säätely Sutinen, Siiri; Niskanen, Einari. 2020. Histonien muokkaukset ja geenien säätely SOLUBIOLOGI 1: 12-21. 2020
• Integrative proteomics of prostate cancer Scaravilli, M; Afyounian, E; Nykter, M; Visakorpi, T; Latonen, L. 2020. Integrative proteomics of prostate cancer Current opinion in endocrine and metabolic research 10: 43-49. 2020
• New insights into the genetic basis of premature ovarian insufficiency: novel causative variants and candidate genes revealed by genomic sequencing Jaillard, Sylvie; Bell, Katrina; Akloul, Linda; Walton, Kelly; McElreavy, Kenneth; Stocker, William A; Beaumont, Marion; Harrisson, Craig; Jääskeläinen, Tiina; Palvimo, Jorma J; Robevska, Gorjana; Launay, Erika; Satié, Anne-Pascale; Listyasari, Nurin; Bendavid, Claude; Sreenivasan, Rajini; Duros, Solène; van den Bergen, Jocelyn; Henry, Catherine; Domin-Bernhard, Mathilde et al.. 2020. New insights into the genetic basis of premature ovarian insufficiency: novel causative variants and candidate genes revealed by genomic sequencing Maturitas 141: 9-19. 2020
• Glucocorticoid receptor quaternary structure drives chromatin occupancy and transcriptional outcome Paakinaho, V; Johnson, TA; Presman, DM; Hager, GL. 2019. Glucocorticoid receptor quaternary structure drives chromatin occupancy and transcriptional outcome Genome research 29 8: 1223-1234. 2019
• IRF2BP2 Modulates the Crosstalk between Glucocorticoid and TNF Signaling Kaiser Manjur, ABM; Lempiäinen, Joanna K; Malinen, Marjo; Palvimo, Jorma J; Niskanen, Einari A. 2019. IRF2BP2 Modulates the Crosstalk between Glucocorticoid and TNF Signaling Journal of steroid biochemistry and molecular biology 192: 105382. 2019
• Lack of androgen receptor SUMOylation results in male infertility due to epididymal dysfunction Zhang, Fu-Ping; Malinen, Marjo; Mehmood, Arfa; Lehtiniemi, Tiina; Jääskeläinen, Tiina; Niskanen, Einari A; Korhonen, Hanna; Laiho, Asta; Elo, Laura L; Ohlsson, Claes; Kotaja, Noora; Poutanen, Matti; Sipilä, Petra; Palvimo, Jorma J. 2019. Lack of androgen receptor SUMOylation results in male infertility due to epididymal dysfunction Nature communications 10: 777. 2019
• Meta-analysis of Chromatin Programming by Steroid Receptors Paakinaho, Ville; Swinstead, Erin E; Presman, Diego M; Grøntved, Lars; Hager, Gordon L. 2019. Meta-analysis of Chromatin Programming by Steroid Receptors Cell reports 28 13: 3523-3534. 2019
• TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile Dendoncker, K; Timmermans, S; Vandewalle, J; Eggermont, M; Lempiäinen, J; Van Hamme, E; Dewaele, S; Vandevyver, S; Ballegeer, M; Souffriau, J; Van Wyngene, L; Van Looveren, K; Vanderhaeghen, T; Beyaert, R; De Bosscher, K; Palvimo, JJ; Van Montagu, M; Libert, C. 2019. TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile Proceedings of the National Academy of Sciences of the United States of America 116 26: 12942-12951. 2019
• The ß2-adrenergic receptor is a molecular switch for neuroendocrine transdifferentiation of prostate cancer cells Braadland, PR; Ramberg, H; Grytli, HH; Urbanucci, A; Nielsen, HK; Guldvik, IJ; Engedal, A; Ketola, K; Wang, W; Svindland, A; Mills, IG; Bjartell, A; Tasken, KA. 2019. The ß2-adrenergic receptor is a molecular switch for neuroendocrine transdifferentiation of prostate cancer cells Molecular cancer research 17 11: 2154-21681-15. 2019
• Androgen receptor SUMOylation regulates bone mass in male mice Wu, Jianyao; Movérare-Skrtic, Sofia; Zhang, Fu-Ping; Koskela, Antti; Tuukkanen, Juha; Palvimo, Jorma J; Sipilä, Petra; Poutanen, Matti; Ohlsson, Claes. 2018. Androgen receptor SUMOylation regulates bone mass in male mice MOLECULAR AND CELLULAR ENDOCRINOLOGY 479: 117-122. 2018
• Chromatin reprogramming in breast cancer Swinstead, Erin E; Paakinaho, Ville; Hager, Gordon L. 2018. Chromatin reprogramming in breast cancer. ENDOCRINE-RELATED CANCER 25 7: R385-R404. 2018
• Response: Commentary: Analysis of SUMO1-conjugation at synapses Daniel, James A; Cooper, Benjamin H; Palvimo, Jorma J; Zhang, Fu-Ping; Brose, Nils; Tirard, Marilyn. 2018. Response: Commentary: Analysis of SUMO1-conjugation at synapses Frontiers in cellular neuroscience 12: 117. 2018
• Agonist-specific Protein Interactomes of Glucocorticoid and Androgen Receptor as Revealed by Proximity Mapping Lempiäinen Joanna K, Niskanen Einari A, Vuoti Kaisa-Mari, Lampinen Riikka E, Göös Helka, Varjosalo Markku, Palvimo Jorma J. 2017. Agonist-specific Protein Interactomes of Glucocorticoid and Androgen Receptor as Revealed by Proximity Mapping. Molecular & Cellular Proteomics 16 8: 1462-1474. 2017
• Analysis of SUMO1-conjugation at Synapses Daniel JA, Cooper BH, Palvimo JJ, Zhang FP, Brose N, Tirard M. 2017. Analysis of SUMO1-conjugation at Synapses. Elife 6: e26338. 2017
• Androgen Receptor Androgen Receptor. Sutinen, Päivi; Malinen, Marjo; Palvimo, Jorma J / Endocrinology of the Testis and Male Reproduction. 2017. 2017
• Chromatin SUMOylation in heat stress : to protect, pause and organise? Niskanen Einari A, Palvimo Jorma J. 2017. Chromatin SUMOylation in heat stress : to protect, pause and organise?. BIOESSAYS 39 6: 1600263. 2017
• Complete androgen insensitivity syndrome caused by a deep intronic pseudoexon-activating mutation in the androgen receptor gene Känsäkoski Johanna, Jääskeläinen Jarmo, Jääskeläinen Tiina, Tommiska Johanna, Saarinen Lilli, Lehtonen Rainer, Hautaniemi Sampsa, Frilander Mikko J, Palvimo Jorma J, Toppari Jorma, Raivio Taneli. 2016. Complete androgen insensitivity syndrome caused by a deep intronic pseudoexon-activating mutation in the androgen receptor gene. Scientific Reports 6: 32819. 2016
• Crosstalk between androgen and pro-inflammatory signaling remodels androgen receptor and NF-kB cistrome to reprogram the prostate cancer cell transcriptome Malinen Marjo, Niskanen Einari A, Kaikkonen Minna U, Palvimo Jorma J. 2016. Crosstalk between androgen and pro-inflammatory signaling remodels androgen receptor and NF-kB cistrome to reprogram the prostate cancer cell transcriptome. NUCLEIC ACIDS RESEARCH 45 2: 619-630. 2016
• Global analysis of transcription in castration-resistant prostate cancer cells uncovers active enhancers and direct androgen receptor targets Toropainen Sari, Niskanen Einari A, Malinen Marjo, Sutinen Päivi, Kaikkonen Minna U, Palvimo Jorma J. 2016. Global analysis of transcription in castration-resistant prostate cancer cells uncovers active enhancers and direct androgen receptor targets. Scientific Reports 6: 33510. 2016
• Androgen receptor- and PIAS1-regulated gene programs in molecular apocrine breast cancer cells Malinen Marjo, Toropainen Sari, Jääskeläinen Tiina, Sahu Biswajyoti, Jänne Olli A, Palvimo Jorma J. 2015. Androgen receptor- and PIAS1-regulated gene programs in molecular apocrine breast cancer cells. MOLECULAR AND CELLULAR ENDOCRINOLOGY 414: 91-98. 2015
• Cyclin-dependent kinase 5 acts as a critical determinant of AKT-dependent proliferation and regulates differential gene expression by the androgen receptor in prostate cancer cells Lindqvist Julia, Imanishi Susumu Y, Torvaldson Elin, Malinen Marjo, Remes Mika, Örn Fanny, Palvimo Jorma J, Eriksson John E.. 2015. Cyclin-dependent kinase 5 acts as a critical determinant of AKT-dependent proliferation and regulates differential gene expression by the androgen receptor in prostate cancer cells. MOLECULAR BIOLOGY OF THE CELL (BETHESDA MD) 26 11: 1971-1984. 2015
• Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapies Moilanen Anu-Maarit, Riikonen Reetta, Oksala Riikka, Ravanti Laura, Aho Eija, Wohlfahrt Gerd, Nykänen Pirjo S, Törmäkangas Olli P, Palvimo Jorma J, Kallio Pekka J. 2015. Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapies. Scientific Reports 5: -. 2015
• Synthesis and Biological Evaluation of Second-Generation Tropanol-Based Androgen Receptor Modulators Sundén Henrik, Holland Mareike C, Poutiainen Pekka K, Jääskeläinen Tiina, Pulkkinen Juha T, Palvimo Jorma J, Olsson Roger. 2015. Synthesis and Biological Evaluation of Second-Generation Tropanol-Based Androgen Receptor Modulators. JOURNAL OF MEDICINAL CHEMISTRY 58 3: 1569-1574. 2015
• Electrophilic Lipid Mediator 15-Deoxy-Delta12,14-Prostaglandin J2 Modifies Glucocorticoid Signaling via Receptor SUMOylation Paakinaho Ville, Kaikkonen Sanna, Levonen Anna-Liisa, Palvimo Jorma J. 2014. Electrophilic Lipid Mediator 15-Deoxy-Delta12,14-Prostaglandin J2 Modifies Glucocorticoid Signaling via Receptor SUMOylation. MOLECULAR AND CELLULAR BIOLOGY 34 17: 3202-13. 2014
• Genome-wide Regulation of Glucocorticoid Signaling by SUMO Modifications Paakinaho Ville. 2014. Genome-wide Regulation of Glucocorticoid Signaling by SUMO Modifications. Publications of the University of Eastern Finland. Dissertations in Health Sciences 238. 2014
• Nuclear mobility and activity of FOXA1 with androgen receptor are regulated by SUMOylation Sutinen Päivi, Rahkama Vesa, Rytinki Miia, Palvimo Jorma J. 2014. Nuclear mobility and activity of FOXA1 with androgen receptor are regulated by SUMOylation. MOLECULAR ENDOCRINOLOGY 28 10: 1719-1728. 2014
• Preclinical pharmacology of FL442, a novel nonsteroidal androgen receptor modulator Poutiainen Pekka K, Huhtala Tuulia, Jääskeläinen Tiina, Petsalo Aleksanteri, Küblbeck Jenni, Kaikkonen Sanna, Palvimo Jorma J, Raunio Hannu, Närvänen Ale, Peräkylä Mikael, Juvonen Risto O, Honkakoski Paavo, Laatikainen Reino, Pulkkinen Juha T. 2014. Preclinical pharmacology of FL442, a novel nonsteroidal androgen receptor modulator. MOLECULAR AND CELLULAR ENDOCRINOLOGY 387: 8-18. 2014
• SUMO ligase PIAS1 functions as a target gene selective androgen receptor coregulator on prostate cancer cell chromatin Toropainen Sari, Malinen Marjo, Kaikkonen Sanna, Rytinki Miia, Jääskeläinen Tiina, Sahu Biswajyoti, Jänne Olli A, Palvimo Jorma J. 2014. SUMO ligase PIAS1 functions as a target gene selective androgen receptor coregulator on prostate cancer cell chromatin. NUCLEIC ACIDS RESEARCH 2015; 43 2: 848-861. 2014
• Serum androgen bioactivity is low in children with premature adrenarche Liimatta Jani, Laakso Saila, Utriainen Pauliina, Voutilainen Raimo, Palvimo Jorma J, Jääskeläinen Tiina, Jääskeläinen Jarmo. 2014. Serum androgen bioactivity is low in children with premature adrenarche. PEDIATRIC RESEARCH 75 5: 645-650. 2014
• TWIST overexpression predicts biochemical recurrence-free survival in prostate cancer patients treated with radical prostatectomy Raatikainen Sami, Aaltomaa Sirpa, Palvimo Jorma J, Kärjä Vesa, Soini Ylermi. 2014. TWIST overexpression predicts biochemical recurrence-free survival in prostate cancer patients treated with radical prostatectomy. SCANDINAVIAN JOURNAL OF UROLOGY 2015; 49 1: 51-7. 2014
• Type II Transmembrane Serine Protease Gene Variants Associate with Breast Cancer Luostari Kaisa, Hartikainen Jaana M, Tengström Maria, Palvimo Jorma J, Kataja Vesa, Mannermaa Arto, Kosma Veli-Matti. 2014. Type II Transmembrane Serine Protease Gene Variants Associate with Breast Cancer. PLOS ONE [ONLINE] 9 7: e102519. 2014
• Novel non-steroidal compounds as androgen receptor modulators Pulkkinen Juha, Poutiainen Pekka, Oravilahti Tuomas, Palvimo Jorma, Peräkylä Mikael, Laatikainen Reino, Ihalainen Tarja. 2013. Novel non-steroidal compounds as androgen receptor modulators. PCT/FI2012/050995. 2013
• SUMOylation regulates the chromatin occupancy and anti-proliferative gene programs of glucocorticoid receptor Paakinaho V, Kaikkonen S, Makkonen H, Benes V, Palvimo JJ. 2013. SUMOylation regulates the chromatin occupancy and anti-proliferative gene programs of glucocorticoid receptor Nucleic acids research 2014; 42 3: 1575-1592. 2013
• Adrenocortical hormonal activity in 20-year-old subjects born small or appropriate for gestational age Todorova B, Salonen M, Jääskeläinen J, Tapio A, Jääskeläinen T, Palvimo J, Turpeinen U, Hämäläinen E, Räsänen M, Tenhola S, Voutilainen R. 2012. Adrenocortical hormonal activity in 20-year-old subjects born small or appropriate for gestational age. HORMONE RESEARCH IN PAEDIATRICS 77: 294-304. 2012
• Design, synthesis and biological evaluation of nonsteroidal cycloalkane[d]isoxazole-containing androgen receptor modulators Poutiainen Pekka, Oravilahti Tuomas, Peräkylä Mikael, Palvimo Jorma, Ihalainen Janne, Laatikainen Reino, Pulkkinen Juha. 2012. Design, synthesis and biological evaluation of nonsteroidal cycloalkane[d]isoxazole-containing androgen receptor modulators JOURNAL OF MEDICINAL CHEMISTRY 55: 6316-6327. 2012
• Dynamic SUMOylation is linked to the activity cycles of androgen receptor in the cell nucleus Rytinki M, Kaikkonen S, Sutinen P, Paakinaho V, Rahkama V, Palvimo JJ. 2012. Dynamic SUMOylation is linked to the activity cycles of androgen receptor in the cell nucleus. MOLECULAR AND CELLULAR BIOLOGY 32 32: 4195-4205. 2012
• FoxA1 corrupts the antiandrogenic effect of bicalutamide but only weakly attenuates the effect of MDV3100 (Enzalutamide) Belikov S, Öberg C, Jääskeläinen T, Rahkama V, Palvimo JJ, Wrange Ö. 2012. FoxA1 corrupts the antiandrogenic effect of bicalutamide but only weakly attenuates the effect of MDV3100 (Enzalutamide). MOLECULAR AND CELLULAR ENDOCRINOLOGY -: -. 2012
• Glukokortikoidien yhteys masennuksen syntyyn ja oirekuvaan Viinamäki, Heimo; Lehto, Soili M.; Palvimo, Jorma J., Harvima, Ilkka; Valkonen-Korhonen, Minna; Koivumaa-Honkanen, Heli; Hintikka, Jukka; Honkalampi, Kirsi ja Niskanen Leo. 2012. Glukokortikoidien yhteys masennuksen syntyyn ja oirekuvaan DUODECIM 128 10: 1022-1029. 2012
• Histone H2B ubiquitin ligases RNF20 and RNF40 in androgen signaling and prostate cancer cell growth Jääskeläinen T, Makkonen H, Visakorpi T, Jaehoon K, Roeder RG, Palvimo JJ. 2012. Histone H2B ubiquitin ligases RNF20 and RNF40 in androgen signaling and prostate cancer cell growth MOLECULAR AND CELLULAR ENDOCRINOLOGY 350: 87-98. 2012
• Histone demethylase GASC1 - a potential prognostic and predictive marker in invasive breast cancer. Berdel B, Nieminen K, Soini Y, Tengström M, Malinen M, Kosma VM, Palvimo J, Mannermaa A. 2012. Histone demethylase GASC1 - a potential prognostic and predictive marker in invasive breast cancer.. BMC CANCER [ONLINE: HTTP://WWW.BIOMEDCENTRAL.COM/BMCCANCER/] 12 516: e1-15. 2012
• Prostaglandin 15d-PGJ(2) inhibits androgen receptor signaling in prostate cancer cells Kaikkonen S, Paakinaho V, Sutinen P, Levonen AL, Palvimo JJ. 2012. Prostaglandin 15d-PGJ(2) inhibits androgen receptor signaling in prostate cancer cells. MOLECULAR ENDOCRINOLOGY --: e1-12. 2012
• Proto-oncogene PIM-1 is a novel estrogen receptor target associating with high grade breast tumors Malinen M, Jääskeläinen T, Pelkonen M, Heikkinen S, Väisänen S, Kosma VM, Nieminen K, Mannermaa A, Palvimo JJ. 2012. Proto-oncogene PIM-1 is a novel estrogen receptor target associating with high grade breast tumors. MOLECULAR AND CELLULAR ENDOCRINOLOGY - -: -. 2012
• The androgen receptor Palvimo JJ. 2012. The androgen receptor MOLECULAR AND CELLULAR ENDOCRINOLOGY 352: 1-3. 2012
• Analysis of androgen receptor SUMOylaiton Rytinki MM, Kaikkonen S, Sutinen P, Palvimo JJ. 2011. Analysis of androgen receptor SUMOylaiton Methods in Molecular Biology 776: 183-97. 2011
• Analysis of androgen receptor activity by reporter gene assays Makkonen H, Jääskeläinen T, Rytinki MM, Palvimo JJ. 2011. Analysis of androgen receptor activity by reporter gene assays Methods in Molecular Biology 776: 71-80. 2011
• Androgen receptor amplification is reflected in the transcriptional responses of Vertebral-Cancer of the Prostate cells Makkonen H, Kauhanen M, Jääskeläinen T, Palvimo JJ. 2011. Androgen receptor amplification is reflected in the transcriptional responses of Vertebral-Cancer of the Prostate cells MOLECULAR AND CELLULAR ENDOCRINOLOGY 331 1: 57-65. 2011
• Androgen receptor: acting in the three-dimensional chromatin landscape of prostate cancer cells Makkonen H & Palvimo JJ. 2011. Androgen receptor: acting in the three-dimensional chromatin landscape of prostate cancer cells. Hormone Molecular Biology and Clinical Investigation 5 1: 17-26. 2011
• Interleukins 1alfa and 1 beta as regulators of steroidogenesis in human NCI-H295R adrenocortical cells Tkachenko Irina V, Jääskeläinen Tiina, Jääskeläinen Jarmo, Palvimo Jorma J, Voutilainen Raimo. 2011. Interleukins 1alfa and 1 beta as regulators of steroidogenesis in human NCI-H295R adrenocortical cells. STEROIDS (NEW YORK NY) 76: 1103-1115. 2011
• Steroid up-regulation of FKBP51 and its role in hormone signaling Jääskeläinen T, Makkonen H, Palvimo JJ. 2011. Steroid up-regulation of FKBP51 and its role in hormone signaling. CURRENT OPINION IN PHARMACOLOGY 11: 326-331. 2011
• Androgen receptor amplification is reflected in the transcriptional responses of Vertebral-Cancer on the prostate cells Makkonen H, Kauhanen M, Jääskeläinen T & Palvimo JJ. 2010. Androgen receptor amplification is reflected in the transcriptional responses of Vertebral-Cancer on the prostate cells. MOLECULAR AND CELLULAR ENDOCRINOLOGY 331: 57-65. 2010
• Glucocorticoid receptor activates poised FKBP51 locus through long-distance interactions Paakinaho V, Makkonen H, Jääskeläinen T & Palvimo JJ. 2010. Glucocorticoid receptor activates poised FKBP51 locus through long-distance interactions MOLECULAR ENDOCRINOLOGY 24: 511-525. 2010
• SUMOylation can regulate the activity of ETS-like transcription factor 4 Kaikkonen S, Makkonen H, Rytinki M & Palvimo JJ. 2010. SUMOylation can regulate the activity of ETS-like transcription factor 4. BIOCHIMICA ET BIOPHYSICA ACTA 1799: 555-560. 2010
• Long-range activation of FKBP51 transkription by the androgen receptor via distal intronic enhancers Makkonen H, Kauhanen M, Paakinaho V, Jääskeläinen T, Palvimo JJ. 2009. Long-range activation of FKBP51 transkription by the androgen receptor via distal intronic enhancers NUCLEIC ACIDS RESEARCH 37 12: 4135-4148. 2009
• Oestrogen receptors and small nuclear ring finger protei 4 (RNF4) in malignant ovarian germ cell tumors Salonen J, Butzow R, Palvimo JJ, Heikinheimo M, Heikinheimo O. 2009. Oestrogen receptors and small nuclear ring finger protei 4 (RNF4) in malignant ovarian germ cell tumors. MOLECULAR AND CELLULAR ENDOCRINOLOGY 307: 205-210. 2009
• PIAS proteins: pleiotropic interactors associated with SUMO Rytinki MM, Kaikkonen S, Pehkonen P, Jääskeläinen T, Palvimo JJ. 2009. PIAS proteins: pleiotropic interactors associated with SUMO. CELLULAR AND MOLECULAR LIFE SCIENCES: CMLS 66 18: 3029-3041. 2009
• SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylaiton of androgen receptor and moulates gene responses in prostate cancer cells Kaikkonen S, Jääskeläinen T, Karvonen U, Rytinki MM, Makkonen H, Gioeli D, Paschal BM, Palvimo JJ. 2009. SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylaiton of androgen receptor and moulates gene responses in prostate cancer cells. MOLECULAR ENDOCRINOLOGY 23 3: 292-307. 2009
• Identification of ETS-like transcription factor as a novel androgen receptor target in prostate cancer cells Makkonen H, Jääskeläinen T, Pitkänen-Arsiola T, Rytinki M, Waltering KK, Mättö M, Visakorpi T, Palvimo JJ. 2008. Identification of ETS-like transcription factor as a novel androgen receptor target in prostate cancer cells. ONCOGENE (LONDON) 27: 4865-4876. 2008
• Leukemia inhibitory factor as a regulator of steroidogenesis in human NCI-H295R adrenocortical cells Mikhaylova IV, Jääskeläinen T, Jääskeläinen J, Palvimo JJ, Voutilainen R. 2008. Leukemia inhibitory factor as a regulator of steroidogenesis in human NCI-H295R adrenocortical cells JOURNAL OF ENDOCRINOLOGY 199: 435-444. 2008
• An adenosine triphosphatase of the sucrose nonfermenting 2 family, androgen receptor-interacting protein 4, is essential for mouse embryonic development and cell proliferation Zhang F-P, Domanskyi A, Palvimo JJ, Sariola H, Partanen J, Jänne OA. 2007. An adenosine triphosphatase of the sucrose nonfermenting 2 family, androgen receptor-interacting protein 4, is essential for mouse embryonic development and cell proliferation. MOLECULAR ENDOCRINOLOGY 21 6: 1430-1442. 2007
• Expression and localization of androgen receptor-interacting protein-4 in the testis Domanskyi A, Zhang F-P, Nurmio M, Palvimo JJ, Torppari J, Jänne OA. 2007. Expression and localization of androgen receptor-interacting protein-4 in the testis. AMERICAN JOURNAL OF PHYSIOLOGY. ENDOCRINOLOGY AND METABOLISM [PRINTED AND ONLINE: HTTP://AJPENDO.PHYSIOLOGY.ORG/] 292: E153-E522. 2007
• PIAS proteins as regulators of small ubiquitin-related modifier (SUMO) modifications and transcription Palvimo JJ. 2007. PIAS proteins as regulators of small ubiquitin-related modifier (SUMO) modifications and transcription. BIOCHEMICAL SOCIETY TRANSACTIONS 35 6: 1405-1408. 2007
• Androgen receptor regulates nuclear trafficking and nuclear domain residency of corepressor HDAC7 in a ligand.dependent fashion Karvonen U, Jänne OA, Palvimo JJ. 2006. Androgen receptor regulates nuclear trafficking and nuclear domain residency of corepressor HDAC7 in a ligand.dependent fashion EXPERIMENTAL CELL RESEARCH 312: 3165-3183. 2006
• Biochemical characterization of androgen receptor-interacting protein 4 Domanskyi A, Virtanen KT, Palvimo JJ, Jänne OA. 2006. Biochemical characterization of androgen receptor-interacting protein 4 BIOCHEMICAL JOURNAL 393: 789-795. 2006
• Small carboxyl-terminal domain phosphatase 2 attenuates androgen-dependent transcription Thompson J, Lepikhova T, Teixido-Travesa N, Whitehead MA, Palvimo JJ, Jänne OA. 2006. Small carboxyl-terminal domain phosphatase 2 attenuates androgen-dependent transcription. EMBO JOURNAL 25 12: 2757-2767. 2006
• Disruption of the murine PIASx gene results in reduced testis weight Santti H, Mikkonen L, Anand A, Hirvonen-Santti S, Toppari J, Panhuysen M, Vauti F, Perera M, Gorte G, Wurst W, Jänne OA, Palvimo JJ. 2005. Disruption of the murine PIASx gene results in reduced testis weight JOURNAL OF MOLECULAR ENDOCRINOLOGY 34: 645-654. 2005
• FLI-1 functionally interacts with PIASxalpha, a member of the PIAS E3 SUMO ligase family van der Akker E, Ano S, Shih H-M, Wang L-C, Pironin M, Palvimo JJ, Kotaja N, Kirsh O, Dejean A, Chysdael J. 2005. FLI-1 functionally interacts with PIASxalpha, a member of the PIAS E3 SUMO ligase family. JOURNAL OF BIOLOGICAL CHEMISTRY 280 45: 38035-38046. 2005
• Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor Kang Z, Jänne OA, Palvimo JJ. 2004. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor. MOLECULAR ENDOCRINOLOGY 18 11: 2633-2648. 2004